Organofluorides Press Release

Title Picture
11/30/2018 - 18:06
Lupin launches generic Nystatin and Triamcinolone Acetonide Cream USP 100,000 units/gm; 0.1%
Lupin's picture
Lupin
11/27/2018 - 12:22
Two Phase 3 Studies of the Triple Combination of VX-659, Tezacaftor and Ivacaftor Met Primary Endpoint of Improvement in Lung Function (ppFEV1) in People with Cystic Fibrosis
Vertex's picture
Vertex
11/13/2018 - 08:22
Solvay introduces KetaSpire PEEK and Radel PPSU medical grade filaments for additive manufacturing in healthcare
Solvay's picture
Solvay
10/26/2018 - 04:03
Signing of a Memorandum on Clinical Development of Anti-Influenza Virus Drug in China
Fujifilm's picture
Fujifilm
10/24/2018 - 14:54
Solvay to increase Tecnoflon fluoroelastomer production to meet growing customer demand
Solvay's picture
Solvay
10/23/2018 - 13:25
, which discusses steps that can smooth a supermarket owners transition to sustainable and compliant HFO blend refrigerants.
Emerson's picture
Emerson
09/27/2018 - 04:14
Therapy applied directly inside the eye best for treating uveitic macular edema
NIH's picture
NIH
09/24/2018 - 13:20
Solvay to lift PVDF capacity in Europe by 35% addressing booming demand growth for electric vehicle batteries
Solvay's picture
Solvay
07/24/2018 - 16:05
Merck Announces Week 96 Data from Pivotal Phase 3 DRIVE-FORWARD Study of Its Investigational HIV Therapy Doravirine
Merck's picture
Merck
07/23/2018 - 08:32
EGPAF Statement on Guidance Regarding Use of Dolutegravir by Pregnant Women
Ped AIDS's picture
Ped AIDS
07/16/2018 - 09:38
Pfizer and GSKs HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine
MSF's picture
MSF
06/13/2018 - 21:11
ViiV Healthcare reports landmark phase III studies for dolutegravir and lamivudine, demonstrating the ability to control HIV with a two-drug regimen in treatment naive patients
GlaxoSmithKline's picture
GlaxoSmithKline
05/21/2018 - 09:11
GSK receives US approval of Arnuity Ellipta for use in children from 5 years old who suffer from asthma
GlaxoSmithKline's picture
GlaxoSmithKline
05/21/2018 - 07:51
Janssen Announces European Commission Approval of JULUCA (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-1
Johnson and Johnson's picture
Johnson and Johnson
04/30/2018 - 13:01
Solvay introduces next-generation Solef PVDF to enhance protection and performance of rigid and flexible pipes used in oil and gas recovery
Solvay's picture
Solvay
04/25/2018 - 15:53
Anti-HIV drug combination does not increase preterm birth risk, study suggests
NIH's picture
NIH
03/15/2018 - 00:31
Solvay Specialty Polymers to sell its Porto Marghera plant in Italy
Solvay's picture
Solvay
03/08/2018 - 02:42
GSK announces positive EU approval for labelling update to Relvar Ellipta in patients with asthma
GlaxoSmithKline's picture
GlaxoSmithKline
02/20/2018 - 08:48
Mylan Receives Tentative Approval for Combination HIV Treatment DTG/FTC/TAF Under FDA's PEPFAR Program
Mylan's picture
Mylan
02/08/2018 - 06:09
ViiV Healthcare launches eighth phase III study in two-drug regimen programme for HIV-1 treatment
GlaxoSmithKline's picture
GlaxoSmithKline
01/26/2018 - 14:57
MMRC Clinical Trials Highlights
MMRF's picture
MMRF
01/26/2018 - 02:03
GSK announces CHMP positive opinion for labelling update to Relvar Ellipta in patients with asthma
GlaxoSmithKline's picture
GlaxoSmithKline
01/10/2018 - 01:33
New Site Also Provides Public with Access to Health and Safety Research
ACC's picture
ACC
12/11/2017 - 08:06
Reducing the Greenhouse Effect by Promoting HFO Units
pivari's picture
pivari
12/06/2017 - 21:07
Food safety for fishers
MPI NZ's picture
MPI NZ
11/13/2017 - 15:41
3M, Orange Silicon Valley, Allied Control and U.S. Naval Research Laboratory demonstrate high-density supercomputing at SC'17
3M's picture
3M
11/02/2017 - 11:16
Solvay expands its thermal management solutions for automotive with new high-performance Ryton PPS and Amodel PPA specialty polymers
Solvay's picture
Solvay
10/25/2017 - 11:39
Get to Know Changes in Refrigerants (134A to 1234YF)
Association of Equipment Manufacturers's picture
Association of ...
10/23/2017 - 14:44
Solvay launches signal orange colored Ixef 1524 PARA HFFR grade for EV connectors
Solvay's picture
Solvay
09/22/2017 - 07:03
Pharmaceutical Company Paying Penalty for Misleading Investors About Sales Metric
SEC's picture
SEC
09/22/2017 - 04:26
Honeywell Seeks Rehearing of D.C. Circuit Court Decision Regarding EPA's SNAP Program
Honeywell International's picture
Honeywell Inter...
09/05/2017 - 10:31
Ortho Dermatologics Submits New Drug Application To The U.S. Food And Drug Administration For Psoriasis Treatment IDP-118
Valeant Pharmaceuticals's picture
Valeant Pharmac...
08/10/2017 - 15:18
Courts deal another blow to Obama climate legacy
R Street Institute's picture
R Street Institute
07/26/2017 - 09:38
Mylan Receives WHO Prequalification for Generic Sovaldi
Mylan's picture
Mylan
07/25/2017 - 08:05
Switching to a dolutegravir regimen from a boosted protease inhibitor regimen maintained viral suppression and improved lipid fractions in patients with HIV and high cardiovascular risk
GlaxoSmithKline's picture
GlaxoSmithKline
07/25/2017 - 04:56
Mercks Investigational NNRTI, Doravirine, Meets Primary Efficacy Endpoint of Non-Inferiority to Efavirenz, Both in Combination with Other Antiretroviral Agents, in Pivotal Phase 3 Trial for Treatment of HIV-1 Infection
Merck's picture
Merck
07/24/2017 - 04:25
GSK submits US regulatory filing of Arnuity Ellipta in children with asthma
GlaxoSmithKline's picture
GlaxoSmithKline
07/21/2017 - 04:29
GSK submits EU filing for extended use of Relvar Ellipta in patients with controlled asthma on an ICS/LABA combination
GlaxoSmithKline's picture
GlaxoSmithKline
07/20/2017 - 11:35
ViiV Healthcare shares data from its innovative portfolio with HIV community at IAS 2017
GlaxoSmithKline's picture
GlaxoSmithKline
06/10/2017 - 09:49
Merck and Pfizer Announce That Investigational SGLT-2 Inhibitor Ertugliflozin Met Primary Endpoint in Two Phase 3 Studies
Merck's picture
Merck
06/09/2017 - 02:53
Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide in Patients with Non-metastatic Castration-Resistant Prostate Cancer
Pfizer's picture
Pfizer
06/04/2017 - 05:58
Rexahn Pharmaceuticals Presents Preliminary Efficacy Data from the Ongoing Phase IIa Clinical Trial of RX-3117 in Metastatic Bladder Cancer at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting
Rexahn Pharmaceuticals's picture
Rexahn Pharmace...
06/01/2017 - 04:30
ViiV Healthcare submits regulatory applications for the first HIV maintenance regimen comprising only two medicines
GlaxoSmithKline's picture
GlaxoSmithKline
05/19/2017 - 05:02
Merck Receives CHMP Positive Opinion Recommending Approval of ISENTRESS (raltegravir) 600 mg in the European Union
Merck's picture
Merck
05/17/2017 - 17:47
Pfizer Oncology to Present Data Across 13 Different Types of Cancer at ASCO 2017 Annual Meeting
Pfizer's picture
Pfizer
05/16/2017 - 13:41
Honeywell Starts Up $300 Million Automotive Refrigerant Production Facility In Louisiana
Honeywell's picture
Honeywell
05/16/2017 - 05:49
Merck to Present New Phase 3 Data on Investigational Ertugliflozin, Additional Analyses of Studies of JANUVIA (sitagliptin), and Real-World Evidence Research at the 77th Scientific Sessions of the American Diabetes Association
Merck's picture
Merck
04/27/2017 - 13:13
PPG celebrates 50th anniversary of DURANAR coatings in 2017
PPG's picture
PPG
04/05/2017 - 02:15
New Form of Therapeutic Shows Efficacy Against Castration-resistant Prostate Cancer in Preclinical Studies
American Association for Cancer Research's picture
American Associ...
04/04/2017 - 08:45
Lawsuit Filed to Save Imperiled Native Carnivores From Deadly 'Cyanide Bombs'
Center for Biological Diversity's picture
Center for Biol...
03/20/2017 - 09:48
Mylan Receives Tentative Approval for "TLE400" Under PEPFAR
Mylan's picture
Mylan
03/09/2017 - 17:14
DURANAR XL coatings by PPG add brilliance to new Centre Videotron in Quebec City
PPG's picture
PPG
03/07/2017 - 03:44
New drug combination targets aggressive blood cancer
Van Andel's picture
Van Andel
02/23/2017 - 03:40
Positive results for Relvar Ellipta lung function study in patients with well-controlled asthma
GlaxoSmithKline's picture
GlaxoSmithKline
02/17/2017 - 22:47
Phase II study supports potential for Roches TECENTRIQ (atezolizumab) plus Avastin (bevacizumab) for people with locally advanced or metastatic renal cell carcinoma
Rocheusa's picture
Rocheusa
01/20/2017 - 05:42
Rexahn Pharmaceuticals Presents an Update of the Ongoing Phase IIa Clinical Trial of RX-3117 in Metastatic Pancreatic Cancer at the American Society of Clinical Oncology (ASCO) 2017 Gastrointestinal Cancers Symposium
Rexahn Pharmaceuticals's picture
Rexahn Pharmace...
01/12/2017 - 09:36
Petition Seeks to Halt EPA's Use of Deadly Predator Poison
Center for Biological Diversity's picture
Center for Biol...
12/19/2016 - 02:01
GSK starts phase III study of once-daily closed triple combination therapy FF/UMEC/VI in patients with asthma
GlaxoSmithKline's picture
GlaxoSmithKline
12/14/2016 - 19:13
Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI (enzalutamide) Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer
Pfizer's picture
Pfizer
12/07/2016 - 08:47
tnAcity Data Presented at SABCS Evaluates the Investigational Use of ABRAXANE as First-Line Treatment of Metastatic Triple Negative Breast Cancer
Celgene's picture
Celgene